Half-year report · Q2
4820.TEDINET S100U7CP
Period2024-01-01 → 2024-06-30
Filed2024-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.0bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥20.4bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.8bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | ¥1.2bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.5bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.9bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.5bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥985m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥789m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | ¥784m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥29.3bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥29.4bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥27.2bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.9bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥8.8bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.4bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.6bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.9bn | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.5bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.4bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.5bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.4bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.4bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥371m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥15m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.0bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥993m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥661m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥14 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.76 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.17 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥13.96 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.68 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥11.13 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 69.4% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.6% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.8% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 42
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥79m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥79m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | ¥32m |
| jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥283m |
| jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥283m |
| jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥229m |
| jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥306m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥572m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥502m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥70m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥40m |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥9.0bn |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥9.0bn |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥9m |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.7bn |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥11.1bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥11.0bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥79m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥58m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥58m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | ¥27m |
| jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥278m |
| jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥278m |
| jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥285m |
| jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥7m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥386m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥337m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥48m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥5m |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥7.7bn |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥7.7bn |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥9m |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥9.9bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥9.8bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥58m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 530
| Item | Context | Value | Unit |
|---|---|---|---|
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -2435000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 48000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 8881000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 9441000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 6445000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 9490000000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 1390000000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 1802000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 253000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 323000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 28000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 10000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 7672000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | 1529000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | 278000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember | 337000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 9818000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 9818000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 9000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember | 48000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 58000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -58000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 7681000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | 1529000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | 278000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember | 386000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 9876000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -58000000 | JPY |
| Net sales | Prior1YTDDuration | 9818000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 1405000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | -7000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | -285000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember | 5000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1117000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 27000000 | JPY |
| Operating income | Prior1YTDDuration | 1144000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 9004000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | 1198000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | 283000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember | 502000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 10989000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 10989000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 9000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |